Michael Grün

Dr. Michael Grün


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 April 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
MGMichael Grün
Michael Grün
KRKai Rothaus
Kai Rothaus
MZMartin Ziegler
Martin Ziegler
CLClemens Lange
Clemens Lange
ALAlbrecht Lommatzsch
Albrecht Lommatzsch
Henrik FaatzHenrik Faatz
Henrik Faatz
Background: Anti-Vascular Endothelial Growth Factor (VEGF) therapy is an effective therapy for improving and stabilizing the vision of patients with neovascular age-related macular degeneration (nAMD). However, the treatment requirements, particularly the number of intraocular injections, can vary significantly among patients. This study aimed to analyze the vascular characteristics of macular neovascularizations (MNVs) to identify potential biomarkers that could predict the required injection frequency throughout the disease course. Methods: In all patients, the initial diagnosis of nAMD was confirmed using optic coherence tomography (OCT), fluorescein angiography, and OCT angiography (OCTA). MNVs detected using OCTA were subjected to quantitative vascular analysis of their area, total vascular length (sumL), fractal dimension (FD), and flow density. These results were then correlated with the number of intravitreal anti-VEGF treatments administered during the first 3 years of treatment. Additionally, the relationship between the parameters and visual acuity progression was analyzed. Results: A total of 68 treatment-naïve eyes were included in the study, comprising 31 eyes with type 1 MNV, 19 eyes with type 2 MNV, and 18 eyes with type 3 MNV. The average MNV area at baseline was 1.11 mm2 ± 1.18 mm2, the mean total vascular length was 12.95 mm ± 14.24 mm, the mean fractal dimension was 1.26 ± 0.14, and the mean flow density was 41.19 ± 5.87. On average, patients in our cohort received 19.8 ± 8.5 intravitreal injections (IVIs). A significant correlation was found between the number of administered IVIs in the first 3 treatment years and the MNV area (p < 0.005), sumL (p < 0.005), and FD (p < 0.05), while no correlation was found with flow density. Additionally, there was no significant association between MNV type and treatment requirements, nor between MNV vascular architecture and visual acuity progression. Conclusions: The results suggest that the specific vascular structure of untreated MNV may serve as a predictor of long-term treatment demand. With the emergence of new drug classes and advancements in imaging techniques, these parameters could offer valuable insights for forecasting treatment requirements.

27 May 2026 in Journal of Medical Internet Research
Verified
Journal Article
Open access
BPBroder Poschkamp
Broder Poschkamp
AOAriel Yuhan Ong
Ariel Yuhan Ong
JEJustin Engelmann
Justin Engelmann
MGMichael Grün
Michael Grün
ASAndreas Stahl
Andreas Stahl
DMDavid Merle
David Merle
Artificial intelligence (AI) as a medical device is now progressively entering routine ophthalmic care, yet its impact is still mostly evaluated in terms of diagnostic performance rather than how it reshapes patient care pathways. This viewpoint argues that careful pathway design is crucial to implementing AI in ophthalmology so that it translates into real, practical benefits for patients and services. We propose a framework that classifies AI- and telemedicine-enabled eye care pathways by the initial point of contact and the role of AI: from direct human assessment to grader- or telemedicine-based use to AI-first contact and fully autonomous AI gatekeeping. We apply this framework to 2 contrasting health systems, the United Kingdom and Germany, focusing on common retinal diseases and cardiovascular risk assessment from retinal images. In the United Kingdom, AI is being introduced mainly as a modular upgrade to standardized programs layered onto a gatekeeper model centered on community optometrists and general practitioners. In Germany, direct access to office-based ophthalmologists, opportunistic screening, and commercial retail offerings are producing more fragmented clinician- and market-driven AI adoption. Our comparison shows that the same AI technologies can generate very different patient journeys across health systems. Therefore, their value depends not only on diagnostic performance but also on intentional pathway design, including clear escalation rules and structured information transfer. This includes appropriate task shifting from ophthalmologists to trained staff or new roles, such as image grading, tele-ophthalmology triage, or pathway management. Without such design, AI risks duplicate testing, incomplete or poorly coordinated referrals, and further fragmentation of care.

Verified
Journal Article
Open access
PDF file
MGMichael Grün
Michael Grün
KRKai Rothaus
Kai Rothaus
MZMartin Ziegler
Martin Ziegler
ALAlbrecht Lommatzsch
Albrecht Lommatzsch
CLClemens Lange
Clemens Lange
Henrik FaatzHenrik Faatz
Henrik Faatz
Background/Objectives: To evaluate the potential of Optical Coherence Tomography (OCT) and OCT angiography parameters in predicting treatment requirements and visual outcomes after one year in therapy-naïve eyes with neovascular age-related macular degeneration (nAMD). Methods: A retrospective study of 96 therapy-naïve eyes newly diagnosed with nAMD was carried out. All eyes received baseline OCT and OCTA. Follow-up OCT after initial upload was then carried out, involving three intravitreal injections (IVIs) with anti-Vascular Endothelial Growth Factor (anti-VEGF) at four-week intervals. OCT parameters, including intraretinal fluid (IRF), subretinal fluid (SRF), pigment epithelium detachment (PED), and central retinal thickness (CRT), were assessed qualitatively and quantitatively. Macular Neovascularization (MNV) morphology at baseline was described in terms of area, total vessel length, flow density, and fractal dimension. OCT and OCTA parameters were correlated with best corrected visual acuity (BCVA) and number of administered IVIs after 1 year of treatment. Results: Eyes with persistent subretinal fluid (SRF) or both intraretinal fluid (IRF) and SRF after upload showed a significantly higher need for IVIs (p < 0.01). Also, pigment epithelium detachment (PED) presence at baseline (p < 0.05), PED height at baseline (p < 0.01), PED presence after upload (p < 0.01), and PED height after upload (p < 0.01) were each correlated with a greater number of IVIs. Decrease in PED height during upload was accompanied by a lower number of IVIs (p < 0.01). All the aforementioned parameters had no influence on BCVA after 1 year (p > 0.05). Baseline central retinal thickness (CRT) was linked to worse BCVA at 12 months (p < 0.05), but not the number of IVIs. Follow-up CRT correlated with worse BCVA (p < 0.01) and more IVIs (p < 0.01), while CRT decrease was associated with better BCVA (p < 0.05) and fewer IVIs (p < 0.01) at 1 year. In OCTA, area and total vessel length of MNVs were correlated with BCVA after 1 year (p < 0.01) but had no influence on number of IVIs (p > 0.05). Flow density had no influence on either outcome parameter (p > 0.05). Fractal dimension was associated with BCVA (p < 0.01) and number of IVIs (p < 0.05) after 1 year. Conclusions: MNV area, vessel length, and fractal dimension in OCTA, along with fluid distribution in OCT at baseline and after follow-up, may serve as indicators of treatment needs and visual outcomes after one year. Further studies with longer observation periods and the use of deep learning models are needed to improve analyses and to verify the applicability of these findings to clinical practice.

8 January 2025 in Die Ophthalmologie
Verified
Journal Article
Closed access
PDF file
MGMichael Grün
Michael Grün
MZMartin Ziegler
Martin Ziegler
CLClaudia Lommatzsch
Claudia Lommatzsch
HFHenrik Faatz
Henrik Faatz
GSGeorg Spital
Georg Spital

11 January 2026 in Physiologia
Verified
Journal Article
Open access
PDF file
MGMichael Grün
Michael Grün
KRKai Rothaus
Kai Rothaus
MZMartin Ziegler
Martin Ziegler
ABAlexander Beger
Alexander Beger
ALAlbrecht Lommatzsch
Albrecht Lommatzsch
Henrik FaatzHenrik Faatz
Henrik Faatz
Background: To investigate baseline MNV characteristics in Optical Coherence Tomography Angiography (OCTA) and its impact on therapeutic needs and visual acuity after 5 years in initially therapy-naïve eyes. Methods: A retrospective study of 43 therapy-naïve eyes with neovascular AMD (nAMD). OCTA was performed at baseline and all eyes were observed for 5 years. MNV architecture was characterized by area, total vessel length, flow density and fractal dimension. These variables were tested for correlation with the number of administered intravitreal injections (IVIs) and best-corrected visual outcome (BCVA) after 5 years of treatment. Results: Mean follow-up time was 4.97 ± 0.21 years. Area and total vessel length of MNVs were significantly associated with a higher number of administered IVIs after 5 years (p < 0.05), flow density significantly correlated with fewer IVIs (p < 0.05). Fractal dimension showed a tendency to more IVIs (p = 0.056) after 5 years. Flow density at baseline correlated with a better BCVA (p < 0.05). In contrast, MNV area size, total vessel length and fractal dimension did not show any correlation to BCVA after 5 years (p > 0.05). Conclusions: Specific features of MNV architecture such as area, total vessel length and flow density can predict long-term treatment requirement and visual outcome. Further studies using deep learning algorithms are necessary to explore the usage of these findings in daily practice.